Nille Klæbel joins Atlas Antibodies from her role as CEO Nordics at Philips, a position she has held since 2018.
Nille joined Philips back in 2013. Previously she has held senior positions at GlaxoSmithKline, Sanofi and Novo Nordisk.
“We are delighted to welcome Nille as the new CEO of Atlas Antibodies,” says Torben Jørgensen, chairman of the Board of Directors and continues: “With her strong background in marketing and sales and knowledge of the life sciences, pharma and healthcare industries, Nille is highly equipped to lead the next important steps in the development of Atlas Antibodies into a global life sciences company.”
“I am thrilled to join Atlas Antibodies. The company is at a truly exciting stage right now, having completed two strategic acquisitions. I look forward to contribute to our continued journey of both organic as well as inorganic growth,” says Nille Klæbel.
Photo of Nille Klæbel: Atlas Antibodies
